Polyclonal anti-HMGB1 antibodies have also been implicated in neuropathic pain relief, reduction in neuronal degeneration, downregulation of pro-inflammatory TNF-α, and the restoration of glycemic control in diabetes [120,177,178]. This evidence concerns the gene TNF and diabetes mellitus.